KRAS and neoplasm: Serum HSP90α level in mice was increased with the tumor growth of EndoMT cells-involved PDAC cell grafts, which was consistent with the status of PDAC-developing activated K-Ras knock-in mice and the clinical finding that eHSP90α was increased in the sera of PDAC patients [9].